SIA
BLACU

Schechter Investment Advisors’s Bellevue Life Sciences Acquisition Corp. Unit BLACU Stock Holding History

Schechter Investment Advisors’s Portfolio BLACU Stock Details BLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-52,850
Closed -$559K – 687
2023
Q3 		$559K Sell
52,850
-2,000
-4% -$21.2K 0.05% 321
2023
Q2 		$576K Buy
54,850
+1,750
+3% +$18.2K 0.05% 356
2023
Q1 		$547K Buy
+53,100
New +$544K 0.05% 387

Other funds holding BLACU

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Schechter Investment Advisors's BLACU Position: Q4 2023 in Review

Schechter Investment Advisors sold out of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) in Q4 2023, closing a stake of 52,850 shares — an estimated $559K sold.

Schechter Investment Advisors first reported a position in BLACU in Q1 2023 and held it in 3 quarters. The position peaked at $576K in Q2 2023. 2 funds tracked by Wall St. Rank hold BLACU as of Q4 2023.

  • Schechter Investment Advisors reported no remaining Bellevue Life Sciences Acquisition Corp. Unit position as of Q4 2023 after selling out during the quarter.
  • Schechter Investment Advisors sold 52,850 Bellevue Life Sciences Acquisition Corp. Unit shares in Q4 2023, an estimated $559K.
  • Schechter Investment Advisors first reported a position in Bellevue Life Sciences Acquisition Corp. Unit in Q1 2023 and held it in 3 quarters.
  • Schechter Investment Advisors's Bellevue Life Sciences Acquisition Corp. Unit position peaked at $576K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Bellevue Life Sciences Acquisition Corp. Unit as of Q4 2023.

Based on Schechter Investment Advisors's 13F filing for Q4 2023, filed 17 Jan 2024.